BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28633075)

  • 1. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift.
    Al-Mamgani A; Verheij M; van den Brekel MWM
    Eur J Cancer; 2017 Sep; 82():1-5. PubMed ID: 28633075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
    de Veij Mestdagh PD; Schreuder WH; Vogel WV; Donswijk ML; van Werkhoven E; van der Wal JE; Dirven R; Karakullukcu B; Sonke JJ; van den Brekel MWM; Marijnen CAM; Al-Mamgani A
    BMC Cancer; 2019 Nov; 19(1):1110. PubMed ID: 31727019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.
    de Veij Mestdagh PD; Jonker MCJ; Vogel WV; Schreuder WH; Donswijk ML; Klop WMC; Al-Mamgani A
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2135-2144. PubMed ID: 29955968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
    de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review.
    Al-Mamgani A; van Werkhoven E; Navran A; Karakullukcu B; Hamming-Vrieze O; Machiels M; van der Velden LA; Vogel WV; Klop WM
    Cancer Treat Rev; 2017 Sep; 59():102-108. PubMed ID: 28779635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Nuyts S; Bollen H; Eisbruch A; Corry J; Strojan P; Mäkitie AA; Langendijk JA; Mendenhall WM; Smee R; DeBree R; Lee AWM; Rinaldo A; Ferlito A
    Head Neck; 2021 Sep; 43(9):2807-2821. PubMed ID: 33871090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
    de Veij Mestdagh PD; Walraven I; Vogel WV; Schreuder WH; van Werkhoven E; Carbaat C; Donswijk ML; van den Brekel MWM; Al-Mamgani A
    Radiother Oncol; 2020 Jun; 147():56-63. PubMed ID: 32240908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
    Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma.
    de Veij Mestdagh PD; van Werkhoven E; Navran A; de Boer JP; Schreuder WH; Vogel WV; Al-Mamgani A
    Clin Transl Radiat Oncol; 2019 Jul; 17():7-13. PubMed ID: 31061901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study.
    Longton E; Lawson G; Bihin B; Mathieu I; Hanin FX; Deheneffe S; Vander Borght T; Laloux M; Daisne JF
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):652-661. PubMed ID: 32294522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy.
    Porceddu SV; Pryor DI; Burmeister E; Burmeister BH; Poulsen MG; Foote MC; Panizza B; Coman S; McFarlane D; Coman W
    Head Neck; 2011 Dec; 33(12):1675-82. PubMed ID: 22076976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized elective irradiation of the clinically node-negative neck in definitive radiotherapy for head and neck squamous cell carcinoma.
    Kou J; Lin L; Jiao CY; Tian MQ; Zhou GQ; Jiang X; Ma J; Qi ZY; Lu Y; Sun Y
    Cancer Commun (Lond); 2021 Apr; 41(4):303-315. PubMed ID: 33636050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-slice SPECT/CT vs. lymphoscintigraphy and intraoperative gamma ray probe for sentinel node mapping in HNSCC.
    Meerwein CM; Sekine T; Veit-Haibach P; Bredell MG; Huber GF; Huellner MW
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1633-1642. PubMed ID: 27837418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of previous radiotherapy on cervical lymph node fine-needle aspiration cytology diagnostic accuracy in head and neck cancers.
    Chiu-Lung Chan R; Chan JY
    Laryngoscope; 2012 Aug; 122(8):1779-81. PubMed ID: 22753142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
    Gupta T; Agarwal J; Jain S; Phurailatpam R; Kannan S; Ghosh-Laskar S; Murthy V; Budrukkar A; Dinshaw K; Prabhash K; Chaturvedi P; D'Cruz A
    Radiother Oncol; 2012 Sep; 104(3):343-8. PubMed ID: 22853852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.